108 related articles for article (PubMed ID: 2993440)
1. Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus.
Wainberg MA; Portnoy JD; Clecner B; Hubschman S; Lagacé-Simard J; Rabinovitch N; Remer Z; Mendelson J
J Infect Dis; 1985 Sep; 152(3):441-8. PubMed ID: 2993440
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
McKenna DB; Neill WA; Norval M
Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
[TBL] [Abstract][Full Text] [Related]
4. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
[TBL] [Abstract][Full Text] [Related]
5. Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections.
Green JA; Weiss PN; Yeh TJ; Spruance SL
J Med Virol; 1985 Jul; 16(3):297-305. PubMed ID: 2993500
[TBL] [Abstract][Full Text] [Related]
6. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of a herpes simplex subunit vaccine.
Cappel R; Sprecher S; De Cuyper F; De Braekeleer J
J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune-specific interferon production.
Klieman RL; Green JA; Spruance SL
J Med Virol; 1985 Jul; 16(3):289-96. PubMed ID: 2993499
[TBL] [Abstract][Full Text] [Related]
9. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis.
Reichman RC; Fisher SE; Dolin R
Am J Med; 1982 Jul; 73(1A):86-90. PubMed ID: 6285740
[TBL] [Abstract][Full Text] [Related]
11. Detection of herpes simplex virus DNA in the peripheral blood during acute recurrent herpes labialis.
Brice SL; Stockert SS; Jester JD; Huff JC; Bunker JD; Weston WL
J Am Acad Dermatol; 1992 Apr; 26(4):594-8. PubMed ID: 1317892
[TBL] [Abstract][Full Text] [Related]
12. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
Wade JC; Day LM; Crowley JJ; Meyers JD
J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
[TBL] [Abstract][Full Text] [Related]
13. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.
Lafferty WE; Coombs RW; Benedetti J; Critchlow C; Corey L
N Engl J Med; 1987 Jun; 316(23):1444-9. PubMed ID: 3033506
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.
Shillitoe EJ; Wilton JM; Lehner T
Infect Immun; 1977 Oct; 18(1):130-7. PubMed ID: 198372
[TBL] [Abstract][Full Text] [Related]
15. Human T cell response to Herpes simplex virus antigen in vitro.
Berle EJ; Thorsby E
Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):31-7. PubMed ID: 6246714
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of herpes simplex labialis. I. Replication of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences.
Spruance SL; Chow FS
J Infect Dis; 1980 Nov; 142(5):671-5. PubMed ID: 6257796
[TBL] [Abstract][Full Text] [Related]
17. Clinical and serological outcome of genital herpes simplex virus (HSV) type 2 inoculation following oral HSV type 1 infection in guinea-pigs.
Bernstein DI; Lee FK; Echler G; Nahmias AJ
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2365-72. PubMed ID: 2550572
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitogen- and antigen-induced lymphocyte blastogenesis by herpes simplex virus.
Plaeger-Marshall S; Smith JW
J Infect Dis; 1978 Oct; 138(4):506-11. PubMed ID: 213497
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous and induced interferon production by peripheral blood leucocytes from control population and patients with herpes genitalis.
Iannello D; Taylor MW; Fife KH; Chen L
J Med Virol; 1987 May; 22(1):25-34. PubMed ID: 3035077
[TBL] [Abstract][Full Text] [Related]
20. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
